DE69818144D1 - Derivate des Antibiotikums A82846B (Chloroorienticin A) - Google Patents

Derivate des Antibiotikums A82846B (Chloroorienticin A)

Info

Publication number
DE69818144D1
DE69818144D1 DE69818144T DE69818144T DE69818144D1 DE 69818144 D1 DE69818144 D1 DE 69818144D1 DE 69818144 T DE69818144 T DE 69818144T DE 69818144 T DE69818144 T DE 69818144T DE 69818144 D1 DE69818144 D1 DE 69818144D1
Authority
DE
Germany
Prior art keywords
derivatives
chloroorienticin
antibiotic
hexapeptides
disacc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69818144T
Other languages
English (en)
Other versions
DE69818144T2 (de
Inventor
Richard Craig Thompson
Stephen Charles Wilkie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69818144D1 publication Critical patent/DE69818144D1/de
Publication of DE69818144T2 publication Critical patent/DE69818144T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69818144T 1997-05-20 1998-05-05 Derivate des Antibiotikums A82846B (Chloroorienticin A) Expired - Fee Related DE69818144T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4716597P 1997-05-20 1997-05-20
US47165P 1997-05-20

Publications (2)

Publication Number Publication Date
DE69818144D1 true DE69818144D1 (de) 2003-10-23
DE69818144T2 DE69818144T2 (de) 2004-07-15

Family

ID=21947405

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69818144T Expired - Fee Related DE69818144T2 (de) 1997-05-20 1998-05-05 Derivate des Antibiotikums A82846B (Chloroorienticin A)

Country Status (11)

Country Link
US (1) US5952310A (de)
EP (1) EP0879825B1 (de)
JP (1) JP4150430B2 (de)
AT (1) ATE250082T1 (de)
AU (1) AU7284798A (de)
CA (1) CA2290724C (de)
DE (1) DE69818144T2 (de)
DK (1) DK0879825T3 (de)
ES (1) ES2206840T3 (de)
PT (1) PT879825E (de)
WO (1) WO1998052596A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69936052T2 (de) * 1998-05-01 2008-01-17 Eli Lilly And Co., Indianapolis N1 modifizierte glycopeptide
CN1249081C (zh) 1998-12-23 2006-04-05 施万制药 糖肽衍生物或含有它们的药物组合物
US8652504B2 (en) 2005-09-22 2014-02-18 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
EP1926780B1 (de) 2005-09-22 2013-08-14 Medivas, LLC Bis-( -amino)-diol-diester-haltige poly(esteramid) und poly(esterurethan)-zusammensetzungen und verwendungsverfahren
US8841440B2 (en) 2008-04-01 2014-09-23 Cornell University Organo-soluble chitosan salts and chitosan-derived biomaterials prepared thereof
CN102250221A (zh) * 2010-05-19 2011-11-23 复旦大学 万古霉素类衍生物及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US4643987A (en) * 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
EG18377A (en) * 1986-09-19 1993-04-30 Lilly Co Eli Process for preparing glycopeptide antibiotics
US5534420A (en) * 1988-07-28 1996-07-09 Eli Lilly And Company Biotransformation of glycopeptide antibiotics
ATE160360T1 (de) * 1989-07-18 1997-12-15 Biosearch Italia Spa Aus dalbaheptide hergestellte pentapeptid- antibiotika
IL96603A (en) * 1989-12-13 1998-02-08 Lilly Co Eli Antibacterial glycopeptide derivativesProcess for their preparation and pharmaceutical preparations containing the same
TW213468B (de) * 1991-06-29 1993-09-21 Hoechst Ag
MY128335A (en) * 1994-01-28 2007-01-31 Lilly Co Eli Glycopeptide antibiotic derivatives
US5919756A (en) * 1996-06-28 1999-07-06 Eli Lilly And Company Amides

Also Published As

Publication number Publication date
JP2001526681A (ja) 2001-12-18
EP0879825B1 (de) 2003-09-17
AU7284798A (en) 1998-12-11
EP0879825A2 (de) 1998-11-25
EP0879825A3 (de) 1999-11-24
ATE250082T1 (de) 2003-10-15
DE69818144T2 (de) 2004-07-15
ES2206840T3 (es) 2004-05-16
CA2290724A1 (en) 1998-11-26
DK0879825T3 (da) 2004-02-02
PT879825E (pt) 2004-02-27
US5952310A (en) 1999-09-14
JP4150430B2 (ja) 2008-09-17
CA2290724C (en) 2010-03-23
WO1998052596A1 (en) 1998-11-26

Similar Documents

Publication Publication Date Title
WO1998007745A3 (en) Compositions and methods for treating infections using analogues of indolicidin
WO2001098328A3 (en) Glycopeptide phosphonate derivatives
DE69711766T2 (de) Derivate von Amiden glycopeptidischer Antibiotica
PT688789E (pt) Processo de lipopeptideos processo para a sua preparacao e sua utilizacao
EP0881229A3 (de) Antibiotisch wirksame, alkylierte Hexapeptide
ATE331037T1 (de) Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff
DE69818144D1 (de) Derivate des Antibiotikums A82846B (Chloroorienticin A)
ATE361931T1 (de) N1 modifizierte glycopeptide
AU5696298A (en) Keratinocyte growth factors and uses thereof
EP1174439A3 (de) Zusammensetzungen und Methoden zur Behandlung von Infektionen unter Verwendung von Indolicidinanalogen
WO2001098326A3 (en) Glycopeptide disulfide and thioester derivatives
EP0881230A3 (de) Harnstoff- und Thioharnstoffderivate von antibiotisch wirksamen Glykopeptiden
NO20023761D0 (no) Selektiv N-acylering av A82846 glykopeptidanaloger
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
TWI231815B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents
EP1122245A3 (de) 2-Amino-Benzoxazinone zur Behandlung von viralen Infektionen
MXPA03009803A (es) Antibioticos de glicopeptidos.
AU4063793A (en) Aqueous hexapeptide compositions

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8339 Ceased/non-payment of the annual fee